In this episode, we are joined by Drs. John Kempen and Sapna Gangaputra to review the many ways the SITE cohort study has shaped the way we approach uveitis.

Drs. Kempen and Gangaputra have received grant support from the NIH for their work on the SITE cohort study.

In this episode we are joined by Drs. Debra Goldstein and Mark Dacey to discuss the manifestations, treatment approach and special considerations for ocular syphilis.

The discussants report no relevant financial disclosures.

In this episode, we are joined by Drs. Jennifer Thorne and Parisa Emami to discuss diagnostic and therapeutic approaches in the management of uveitic CNV.

Disclosures:
Dr. Kopplin: None
Dr. Thomas: Consultant for Allergan, Genentech
Dr. Thorne: None
Dr. Emami: Consultant for Genentech

Here we are joined by Drs. Justine Smith and Emilio Dodds to discuss the clinical features and treatment approach in toxoplasma chorioretinitis.

The discussants report no relevant financial disclosures.

In this episode, we are joined by Drs. Alan Palestine and Karen Armbrust to discuss the approach the diagnosis and managament of the many forms of scleritis.

The discussants report no relevant financial disclosures.

Today we are joined by Drs. Rupesh Agrawal and Dilraj Grewal to discuss the myriad of clinical findings and treatment approaches in ocular tuberculosis.

The discussants report no relevant financial disclosures.

In this episode, we are joined by Drs. Arjun Sood and Sruthi Arepalli to discuss diagnostic and therapeutic approaches in the management of uveitic macular edema.

Disclosures:
Dr. Kopplin: Principal Investigator in clinical study sponsored by Roche
Dr. Thomas: Principal Investigator in clinical studies sponsored by Roche and Alimera. Consultant for Alimera, Allergan, EyePoint
Dr. Sood: Consultant for Alimera and EyePoint
Dr. Arepalli: Consultant for EyePoint

Today we are joined by Drs. Jennifer Cao and Edmund Tsui to discuss the spectrum of ocular disease in VKH syndrome.

The discussants report no relevant financial disclosures.